Scholars Central

CommentaryPublished 28 Aug 2023

Evaluating the Efficacy and Safety of Novel Therapeutic in Phase 3 Clinical Trial

Authors: Angelica Merlot

Annals of Clinical Trials and Vaccines Research

Volume 13 · Issue 4 · Pages 125–127

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Phase 3 clinical trials are a critical and pivotal stage in the drug development process, aimed at evaluating the safety and efficacy of a new medical intervention in a large and diverse patient population. These trials follow the successful completion of Phase 1 and Phase 2 studies, which assessed the investigational product’s safety profile, dosage range, and initial efficacy. Phase 3 trials are designed to provide substantial evidence to support the regulatory approval of the new drug or medical intervention and are considered the last step before potential market release.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnnals of Clinical Trials and Vaccines Research
  • SubjectPharmaceutical Sciences
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Angelica Merlot”